Comparison Between Unihemispheric and Bihemispheric TCDS in Subacute Ischemic Stroke Patients (NCT04770363) | Clinical Trial Compass
CompletedNot Applicable
Comparison Between Unihemispheric and Bihemispheric TCDS in Subacute Ischemic Stroke Patients
Egypt36 participantsStarted 2021-02-01
Plain-language summary
This is a randomized clinical trial to study the effect of tDCS in participants with subacute ischemic stroke, the study participants will be randomly assigned into three groups; bihemispheric, unihemispheric and sham group.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Those patients had stroke in the last 3-6 months.
* Subcortical stroke of middle cerebral artery (MCA), caused unilateral hemiplegia.
* National institute of health stroke scale (NIHSS) motor deficits section with score 2 to 15.
Exclusion Criteria:
* Patient with second onset of stroke or history of Transient ischemic attack (TIA)
* Metallic Implant or heart pacemakers.
* Primary cerebral or subarachnoid hemorrhagic stroke.
* Seizure or epilepsy or history of epilepsy at the family.
* Intracranial abscess or brain tumor.
* Cardiovascular disease myocardial infarction, heart failure (unstable cardiac status).
* Atrial Fibrillation or paroxysmal AF in the last 30 days.
* Congenital heart diseases.
* Presence of any other neurological or psychiatric disorder.
* Cognitive/consciousness disorders.
* Oher conditions should be excluded (e.g. tumor, cancer, rheumatologic, Lung disease related to infection, renal/ hepatic diseases, deep venous thrombosis and autoimmune diseases).
* Speech disorders (Dysarthria \& Aphasia).
* NIH Stroke score above 25, will be excluded.
* Patients who underwent thrombolytic therapy or any vascular interventions.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.